Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2009 1
2011 2
2012 4
2013 14
2014 20
2015 20
2016 2
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

65 results

Results by year

Filters applied: . Clear all
Your search was processed without automatic term mapping because it retrieved zero results.
Page 1
Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes.
ADVANCE Collaborative Group; Patel A, MacMahon S, Chalmers J, Neal B, Billot L, Woodward M, Marre M, Cooper M, Glasziou P, Grobbee D, Hamet P, Harrap S, Heller S, Liu L, Mancia G, Mogensen CE, Pan C, Poulter N, Rodgers A, Williams B, Bompoint S, de Galan BE, Joshi R, Travert F. ADVANCE Collaborative Group, et al. N Engl J Med. 2008 Jun 12;358(24):2560-72. doi: 10.1056/NEJMoa0802987. Epub 2008 Jun 6. N Engl J Med. 2008. PMID: 18539916 Free article. Clinical Trial.
Intensive control reduced the incidence of combined major macrovascular and microvascular events (18.1%, vs. 20.0% with standard control; hazard ratio, 0.90; 95% confidence interval [CI], 0.82 to 0.98; P=0.01), as well as that of major microvascular events (9.4% vs. 10.9%; …
Intensive control reduced the incidence of combined major macrovascular and microvascular events (18.1%, vs. 20.0% with standard control; ha …
Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease.
Salloway S, Sperling R, Fox NC, Blennow K, Klunk W, Raskind M, Sabbagh M, Honig LS, Porsteinsson AP, Ferris S, Reichert M, Ketter N, Nejadnik B, Guenzler V, Miloslavsky M, Wang D, Lu Y, Lull J, Tudor IC, Liu E, Grundman M, Yuen E, Black R, Brashear HR; Bapineuzumab 301 and 302 Clinical Trial Investigators. Salloway S, et al. N Engl J Med. 2014 Jan 23;370(4):322-33. doi: 10.1056/NEJMoa1304839. N Engl J Med. 2014. PMID: 24450891 Free PMC article. Clinical Trial.
At week 78, the between-group differences in the change from baseline in the ADAS-cog11 and DAD scores (bapineuzumab group minus placebo group) were -0.2 (P=0.80) and -1.2 (P=0.34), respectively, in the carrier study; the corresponding differences in the noncarrier …
At week 78, the between-group differences in the change from baseline in the ADAS-cog11 and DAD scores (bapineuzumab group minus placebo gro …
Regression of Graft Steatosis After Liver Transplantation.
Meyer H, Maurer MH, Staufer K, Berzigotti A, Banz V; Swiss Transplant Cohort Study. Meyer H, et al. Prog Transplant. 2022 Dec;32(4):321-326. doi: 10.1177/15269248221122868. Epub 2022 Aug 31. Prog Transplant. 2022. PMID: 36047000
Explant macrovesicular steatosis was associated with presence of steatosis 1 year after transplantation (binary logistic regression model, p = 0.014), but not macrovesicular steatosis in the donor graft at time-point of transplantation. ...
Explant macrovesicular steatosis was associated with presence of steatosis 1 year after transplantation (binary logistic regression model, …
Evidence for Collective Multiparticle Correlations in p-Pb Collisions.
Khachatryan V, Sirunyan AM, Tumasyan A, Adam W, Bergauer T, Dragicevic M, Erö J, Friedl M, Frühwirth R, Ghete VM, Hartl C, Hörmann N, Hrubec J, Jeitler M, Kiesenhofer W, Knünz V, Krammer M, Krätschmer I, Liko D, Mikulec I, Rabady D, Rahbaran B, Rohringer H, Schöfbeck R, Strauss J, Treberer-Treberspurg W, Waltenberger W, Wulz CE, Mossolov V, Shumeiko N, Suarez Gonzalez J, Alderweireldt S, Bansal S, Cornelis T, De Wolf EA, Janssen X, Knutsson A, Lauwers J, Luyckx S, Ochesanu S, Rougny R, Van De Klundert M, Van Haevermaet H, Van Mechelen P, Van Remortel N, Van Spilbeeck A, Blekman F, Blyweert S, D'Hondt J, Daci N, Heracleous N, Keaveney J, Lowette S, Maes M, Olbrechts A, Python Q, Strom D, Tavernier S, Van Doninck W, Van Mulders P, Van Onsem GP, Villella I, Caillol C, Clerbaux B, De Lentdecker G, Dobur D, Favart L, Gay AP, Grebenyuk A, Léonard A, Mohammadi A, Perniè L, Randle-conde A, Reis T, Seva T, Thomas L, Vander Velde C, Vanlaer P, Wang J, Zenoni F, Adler V, Beernaert K, Benucci L, Cimmino A, Costantini S, Crucy S, Fagot A, Garcia G, Mccartin J, Ocampo Rios AA, Poyraz D, Ryckbosch D, Salva Diblen S, Sigamani M, Strobbe N, Thyssen F, Tytgat M, Yazgan E, Zaganidis N, Basegmez S, B… See abstract for full author list ➔ Khachatryan V, et al. Phys Rev Lett. 2015 Jul 3;115(1):012301. doi: 10.1103/PhysRevLett.115.012301. Epub 2015 Jun 29. Phys Rev Lett. 2015. PMID: 26182092 Free article.
The p-Pb data, corresponding to an integrated luminosity of 35 nb-1, were collected during the 2013 LHC p-Pb run at a nucleon-nucleon center-of-mass energy of 5.02 TeV by the CMS experiment. ...For both the p-Pb and PbPb systems, the v2 values obtained with c …
The p-Pb data, corresponding to an integrated luminosity of 35 nb-1, were collected during the 2013 LHC p-Pb run at a nucleon- …
Interleukin-2 therapy in patients with HIV infection.
INSIGHT-ESPRIT Study Group; SILCAAT Scientific Committee; Abrams D, Lévy Y, Losso MH, Babiker A, Collins G, Cooper DA, Darbyshire J, Emery S, Fox L, Gordin F, Lane HC, Lundgren JD, Mitsuyasu R, Neaton JD, Phillips A, Routy JP, Tambussi G, Wentworth D. INSIGHT-ESPRIT Study Group, et al. N Engl J Med. 2009 Oct 15;361(16):1548-59. doi: 10.1056/NEJMoa0903175. N Engl J Med. 2009. PMID: 19828532 Free PMC article. Clinical Trial.
Hazard ratios for opportunistic disease or death from any cause with interleukin-2 plus antiretroviral therapy (vs. antiretroviral therapy alone) were 0.91 (95% confidence interval [CI], 0.70 to 1.18; P=0.47) in the SILCAAT study and 0.94 (95% CI, 0.75 to 1.16; P=0. …
Hazard ratios for opportunistic disease or death from any cause with interleukin-2 plus antiretroviral therapy (vs. antiretroviral therapy a …
Measurement of prompt psi(2S) to J/psi yield ratios in Pb-Pb and p-p collisions at sqrt[sNN]=2.76 TeV.
Khachatryan V, Sirunyan AM, Tumasyan A, Adam W, Bergauer T, Dragicevic M, Erö J, Fabjan C, Friedl M, Frühwirth R, Ghete VM, Hartl C, Hörmann N, Hrubec J, Jeitler M, Kiesenhofer W, Knünz V, Krammer M, Krätschmer I, Liko D, Mikulec I, Rabady D, Rahbaran B, Rohringer H, Schöfbeck R, Strauss J, Taurok A, Treberer-Treberspurg W, Waltenberger W, Wulz CE, Mossolov V, Shumeiko N, Suarez Gonzalez J, Alderweireldt S, Bansal M, Bansal S, Cornelis T, De Wolf EA, Janssen X, Knutsson A, Luyckx S, Ochesanu S, Roland B, Rougny R, Van De Klundert M, Van Haevermaet H, Van Mechelen P, Van Remortel N, Van Spilbeeck A, Blekman F, Blyweert S, D'Hondt J, Daci N, Heracleous N, Keaveney J, Lowette S, Maes M, Olbrechts A, Python Q, Strom D, Tavernier S, Van Doninck W, Van Mulders P, Van Onsem GP, Villella I, Caillol C, Clerbaux B, De Lentdecker G, Dobur D, Favart L, Gay AP, Grebenyuk A, Léonard A, Mohammadi A, Perniè L, Reis T, Seva T, Thomas L, Vander Velde C, Vanlaer P, Wang J, Adler V, Beernaert K, Benucci L, Cimmino A, Costantini S, Crucy S, Dildick S, Fagot A, Garcia G, Mccartin J, Ocampo Rios AA, Ryckbosch D, Salva Diblen S, Sigamani M, Strobbe N, Thyssen F, Tytgat M, Yazgan E, Zaganidis N, Basegmez … See abstract for full author list ➔ Khachatryan V, et al. Phys Rev Lett. 2014 Dec 31;113(26):262301. doi: 10.1103/PhysRevLett.113.262301. Epub 2014 Dec 31. Phys Rev Lett. 2014. PMID: 25615312 Free article.
The ratio between the prompt psi(2S) and J/psi yields, reconstructed via their decays into mu+ mu-, is measured in Pb-Pb and p-p collisions at sqrt[sNN]=2.76 TeV. The analysis is based on Pb-Pb and p-p data samples collected by CMS at the Large Hadron …
The ratio between the prompt psi(2S) and J/psi yields, reconstructed via their decays into mu+ mu-, is measured in Pb-Pb and p-p
Observation of a new Ξb baryon.
Chatrchyan S, Khachatryan V, Sirunyan AM, Tumasyan A, Adam W, Bergauer T, Dragicevic M, Erö J, Fabjan C, Friedl M, Frühwirth R, Ghete VM, Hammer J, Hörmann N, Hrubec J, Jeitler M, Kiesenhofer W, Knünz V, Krammer M, Liko D, Mikulec I, Pernicka M, Rahbaran B, Rohringer C, Rohringer H, Schöfbeck R, Strauss J, Taurok A, Wagner P, Waltenberger W, Walzel G, Widl E, Wulz CE, Mossolov V, Shumeiko N, Suarez Gonzalez J, Bansal S, Cornelis T, De Wolf EA, Janssen X, Luyckx S, Maes T, Mucibello L, Ochesanu S, Roland B, Rougny R, Selvaggi M, Staykova Z, Van Haevermaet H, Van Mechelen P, Van Remortel N, Van Spilbeeck A, Blekman F, Blyweert S, D'Hondt J, Gonzalez Suarez R, Kalogeropoulos A, Maes M, Olbrechts A, Van Doninck W, Van Mulders P, Van Onsem GP, Villella I, Charaf O, Clerbaux B, De Lentdecker G, Dero V, Gay AP, Hreus T, Léonard A, Marage PE, Reis T, Thomas L, Vander Velde C, Vanlaer P, Wang J, Adler V, Beernaert K, Cimmino A, Costantini S, Garcia G, Grunewald M, Klein B, Lellouch J, Marinov A, McCartin J, Ocampo Rios AA, Ryckbosch D, Strobbe N, Thyssen F, Tytgat M, Vanelderen L, Verwilligen P, Walsh S, Yazgan E, Zaganidis N, Basegmez S, Bruno G, Castello R, Ceard L, Delaere C, du Pree T,… See abstract for full author list ➔ Chatrchyan S, et al. Phys Rev Lett. 2012 Jun 22;108(25):252002. doi: 10.1103/PhysRevLett.108.252002. Epub 2012 Jun 21. Phys Rev Lett. 2012. PMID: 23004588 Free article.
The mass difference of the peak is 14.84 0.74(stat) 0.28(syst) MeV. The new state most likely corresponds to the J(P) = 3/2(+) companion of the xi(b)....
The mass difference of the peak is 14.84 0.74(stat) 0.28(syst) MeV. The new state most likely corresponds to the J(P) = 3/2(+) compan …
Study of the mass and spin-parity of the Higgs boson candidate via its decays to Z boson pairs.
Chatrchyan S, Khachatryan V, Sirunyan AM, Tumasyan A, Adam W, Aguilo E, Bergauer T, Dragicevic M, Erö J, Fabjan C, Friedl M, Frühwirth R, Ghete VM, Hörmann N, Hrubec J, Jeitler M, Kiesenhofer W, Knünz V, Krammer M, Krätschmer I, Liko D, Mikulec I, Pernicka M, Rabady D, Rahbaran B, Rohringer C, Rohringer H, Schöfbeck R, Strauss J, Taurok A, Waltenberger W, Wulz CE, Mossolov V, Shumeiko N, Suarez Gonzalez J, Alderweireldt S, Bansal M, Bansal S, Cornelis T, De Wolf EA, Janssen X, Luyckx S, Mucibello L, Ochesanu S, Roland B, Rougny R, Van Haevermaet H, Van Mechelen P, Van Remortel N, Van Spilbeeck A, Blekman F, Blyweert S, D'Hondt J, Gonzalez Suarez R, Kalogeropoulos A, Maes M, Olbrechts A, Tavernier S, Van Doninck W, Van Mulders P, Van Onsem GP, Villella I, Clerbaux B, De Lentdecker G, Dero V, Gay AP, Hreus T, Léonard A, Marage PE, Mohammadi A, Reis T, Thomas L, Vander Velde C, Vanlaer P, Wang J, Adler V, Beernaert K, Cimmino A, Costantini S, Garcia G, Grunewald M, Klein B, Lellouch J, Marinov A, McCartin J, Ocampo Rios AA, Ryckbosch D, Sigamani M, Strobbe N, Thyssen F, Tytgat M, Walsh S, Yazgan E, Zaganidis N, Basegmez S, Bruno G, Castello R, Ceard L, Delaere C, du Pree T, Favart D,… See abstract for full author list ➔ Chatrchyan S, et al. Phys Rev Lett. 2013 Feb 22;110(8):081803. doi: 10.1103/PhysRevLett.110.081803. Epub 2013 Feb 21. Phys Rev Lett. 2013. PMID: 23473131 Free article.
Measurement of the Bs(0)→μ+ μ- branching fraction and search for B(0)→μ+ μ- with the CMS experiment.
Chatrchyan S, Khachatryan V, Sirunyan AM, Tumasyan A, Adam W, Bergauer T, Dragicevic M, Erö J, Fabjan C, Friedl M, Frühwirth R, Ghete VM, Hörmann N, Hrubec J, Jeitler M, Kiesenhofer W, Knünz V, Krammer M, Krätschmer I, Liko D, Mikulec I, Rabady D, Rahbaran B, Rohringer C, Rohringer H, Schöfbeck R, Strauss J, Taurok A, Treberer-Treberspurg W, Waltenberger W, Wulz CE, Mossolov V, Shumeiko N, Suarez Gonzalez J, Alderweireldt S, Bansal M, Bansal S, Cornelis T, De Wolf EA, Janssen X, Knutsson A, Luyckx S, Mucibello L, Ochesanu S, Roland B, Rougny R, Staykova Z, Van Haevermaet H, Van Mechelen P, Van Remortel N, Van Spilbeeck A, Blekman F, Blyweert S, D'Hondt J, Kalogeropoulos A, Keaveney J, Lowette S, Maes M, Olbrechts A, Tavernier S, Van Doninck W, Van Mulders P, Van Onsem GP, Villella I, Caillol C, Clerbaux B, De Lentdecker G, Favart L, Gay AP, Hreus T, Léonard A, Marage PE, Mohammadi A, Perniè L, Reis T, Seva T, Thomas L, Vander Velde C, Vanlaer P, Wang J, Adler V, Beernaert K, Benucci L, Cimmino A, Costantini S, Dildick S, Garcia G, Klein B, Lellouch J, Marinov A, Mccartin J, Ocampo Rios AA, Ryckbosch D, Sigamani M, Strobbe N, Thyssen F, Tytgat M, Walsh S, Yazgan E, Zaganidis N, Bas… See abstract for full author list ➔ Chatrchyan S, et al. Phys Rev Lett. 2013 Sep 6;111(10):101804. doi: 10.1103/PhysRevLett.111.101804. Epub 2013 Sep 5. Phys Rev Lett. 2013. PMID: 25166654 Free article.
Measurement of inclusive W and Z boson production cross sections in pp collisions at sqrt[s] = 8 TeV.
Chatrchyan S, Khachatryan V, Sirunyan AM, Tumasyan A, Adam W, Bergauer T, Dragicevic M, Erö J, Fabjan C, Friedl M, Frühwirth R, Ghete VM, Hörmann N, Hrubec J, Jeitler M, Kiesenhofer W, Knünz V, Krammer M, Krätschmer I, Liko D, Mikulec I, Rabady D, Rahbaran B, Rohringer C, Rohringer H, Schöfbeck R, Strauss J, Taurok A, Treberer-Treberspurg W, Waltenberger W, Wulz CE, Mossolov V, Shumeiko N, Suarez Gonzalez J, Alderweireldt S, Bansal M, Bansal S, Cornelis T, De Wolf EA, Janssen X, Knutsson A, Luyckx S, Mucibello L, Ochesanu S, Roland B, Rougny R, Van Haevermaet H, Van Mechelen P, Van Remortel N, Van Spilbeeck A, Blekman F, Blyweert S, D'Hondt J, Kalogeropoulos A, Keaveney J, Maes M, Olbrechts A, Tavernier S, Van Doninck W, Van Mulders P, Van Onsem GP, Villella I, Clerbaux B, De Lentdecker G, Favart L, Gay AP, Hreus T, Léonard A, Marage PE, Mohammadi A, Perniè L, Reis T, Seva T, Thomas L, Vander Velde C, Vanlaer P, Wang J, Adler V, Beernaert K, Benucci L, Cimmino A, Costantini S, Dildick S, Garcia G, Klein B, Lellouch J, Marinov A, Mccartin J, Ocampo Rios AA, Ryckbosch D, Sigamani M, Strobbe N, Thyssen F, Tytgat M, Walsh S, Yazgan E, Zaganidis N, Basegmez S, Beluffi C, Bruno G, Caste… See abstract for full author list ➔ Chatrchyan S, et al. Phys Rev Lett. 2014 May 16;112(19):191802. doi: 10.1103/PhysRevLett.112.191802. Epub 2014 May 14. Phys Rev Lett. 2014. PMID: 24877930 Free article.
65 results